Vaxchora Kit
NDC Package 50632-015-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vaxchora (cholera vaccine, live, oral) kits is vAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in persons 2 through 64 years of age traveling to cholera-affected areas. This formulation utilizes a kit delivery system. Marketed by Bavarian Nordic A/s, this product is identified by NDC 50632-015 and is authorized under FDA application BLA125597.

Identification & Billing

NDC Package Code
50632-015-02
Package Description
1 KIT in 1 CARTON * 1 POWDER, FOR SUSPENSION in 1 PACKET * 1 POWDER, FOR SUSPENSION in 1 PACKET
Product Code
50632-015
11-Digit Billing Format
50632001502
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1812945 - Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
  • RxCUI: 1812945 - Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension
  • RxCUI: 1812951 - Vaxchora 12,000,000 UNT/mL Oral Suspension
  • RxCUI: 1812951 - Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension [Vaxchora]
  • RxCUI: 1812951 - Vaxchora 12000000 UNT/ML Oral Suspension

Clinical Specifications

Proprietary Name
Vaxchora
Non-Proprietary Name
Cholera Vaccine, Live, Oral
Dosage Form
Kit - A packaged collection of related material.
Usage Information
VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in persons 2 through 64 years of age traveling to cholera-affected areas.

Regulatory & Marketing

Labeler Name
Bavarian Nordic A/s
Product Type
Vaccine
FDA Application #
BLA125597
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
06-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50632-015-02 identifies a specific commercial package of 1 kit in 1 carton * 1 powder, for suspension in 1 packet * 1 powder, for suspension in 1 packet of Vaxchora, a vaccine label labeled by Bavarian Nordic A/s. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bavarian Nordic A/s on June 01, 2024. The current certification is valid through December 31, 2026.

How is this Bavarian Nordic A/s product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50632001502. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50632-015-02
11-Digit CMS (5-4-2)
50632-0015-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.